Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Pharma
Teva hit with €463M fine over Copaxone misconduct claims in EU
The European Commission fined Teva 462.6 million euros over claims that it “[abused] its dominant market position to delay competition” to Copaxone.
Fraiser Kansteiner
Oct 31, 2024 10:45am
Biogen raises profit guidance as Leqembi's launch trudges on
Oct 30, 2024 12:30pm
Sanofi unveils new educational website on MS progression
Oct 9, 2024 12:01pm
Roche doubles down with subcutaneous FDA nod for MS star Ocrevus
Sep 13, 2024 1:50pm
Merz to expand and hunt for more deals after closing Inbrija buy
Jul 11, 2024 4:08pm
Roche touts near-complete MS suppression for injectable Ocrevus
Apr 17, 2024 11:00am
